| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 530.621 | 92 |
| GSM780708 | Untreated after 4 days (C2_1) | 502.775 | 92 |
| GSM780709 | Untreated after 4 days (C3_1) | 391.432 | 90 |
| GSM780719 | Untreated after 4 days (C1_2) | 556.047 | 92 |
| GSM780720 | Untreated after 4 days (C2_2) | 559.378 | 92 |
| GSM780721 | Untreated after 4 days (C3_2) | 426.23 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 487.788 | 91 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 500.358 | 92 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 525.071 | 92 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 484.272 | 91 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 474.346 | 91 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 566.226 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 391.76 | 90 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 466.977 | 91 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 467.178 | 91 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 420.036 | 90 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 463.464 | 91 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 501.323 | 92 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 540.653 | 92 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 438.738 | 91 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 527.479 | 92 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 519.206 | 92 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 544.332 | 92 |